Today the war on drugs has begun to lessen its grip, slowly breaking free from the American propaganda that has long dispelled healing properties from any and all illegal drugs. Amidst the discussion on the legality of specified classified drugs, MDMA has been waiting in the wings for its eventual social and federal acceptance with science’s most recent discoveries.
Nearly several weeks ago, the Drug Enforcement Agency approved the usage of MDMA in a study led by, the Multidisciplinary Association for Psychedelic Studies, that will test the efficacy of the drug’s chemical compounds for patients that struggle with painful psychological disorders that are debilitating and often times life threatening.
During this trial, MAPS stated, “18 patients will undergo MDMA-assisted psychotherapy sessions under the supervision of Dr. Philip Wolfson”. Through this form of psychotherapy, MDMA has been reported to allow patients to process difficult emotions, painful memories and relieve deep-rooted anxieties.
A drug that had been deemed a threat and vilified in the ‘80s is now being harnessed as a healing tool for treating PTSD or posttraumatic stress disorder, along with helping those who suffer from psychological and emotional damage caused by sexual assault, war, violent crime and other traumas. Through this form of psychotherapy, patients are administered pure MDMA only several times, rather than ingesting daily pills that are often prescribed for years—or a lifetime—to treat these specific mental illnesses. If a swift wind of change continues to blow, medical grade MDMA could be on the market by 2021.